Compare
Sypris Solutions Inc vs Hurco Companies Inc vs Mesa Laboratories Inc vs Cognex Corp
| Latest fiscal year | Sypris Solutions Inc SYPR | Hurco Companies Inc HURC | Mesa Laboratories Inc MLAB | Cognex Corp CGNX |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-10-31 | 2026-03-31 | 2025-12-31 |
| Revenue | $119.89M | $178.55M | $249.13M | $994.36M |
| Revenue growth (YoY) | -14.5% | -4.3% | +3.4% | +8.7% |
| Gross margin | 7.8% | 18.5% | 63.5% | 66.9% |
| Operating margin | -5.5% | -5.8% | 7.4% | 16.3% |
| Net margin | -5.3% | -8.5% | 2.7% | 11.5% |
| Net income | -$6.34M | -$15.12M | $6.71M | $114.44M |
| EPS (Diluted) | -$0.28 | -$2.34 | $1.21 | $0.68 |
| Operating cash flow | -$5.73M | $17.56M | $42.83M | $245.51M |
| Free cash flow | -$6.49M | $16.65M | $39.58M | $236.77M |
| Cash & equivalents | n/a | $48.71M | $26.93M | $262.93M |
| Total assets | $107.81M | $264.30M | $427.75M | $2.02B |
| Total liabilities | $90.02M | n/a | $241.50M | $524.65M |
| Shareholders' equity | $17.79M | $198.79M | $186.25M | $1.49B |
| Return on year-end equity | -35.6% | -7.6% | 3.6% | 7.7% |
| Shares outstanding | n/a | 6.40M | 5.52M | 167.00M |
Revenue, most recent five fiscal years
| Fiscal year | Sypris Solutions Inc | Hurco Companies Inc | Mesa Laboratories Inc | Cognex Corp |
|---|---|---|---|---|
| Latest | $119.89M Ended 2025-12-31 | $178.55M Ended 2025-10-31 | $249.13M Ended 2026-03-31 | $994.36M Ended 2025-12-31 |
| 1 year earlier | $140.18M Ended 2024-12-31 | $186.58M Ended 2024-10-31 | $240.98M Ended 2025-03-31 | $914.51M Ended 2024-12-31 |
| 2 years earlier | $136.22M Ended 2023-12-31 | $227.81M Ended 2023-10-31 | $216.19M Ended 2024-03-31 | $837.55M Ended 2023-12-31 |
| 3 years earlier | $110.12M Ended 2022-12-31 | $250.81M Ended 2022-10-31 | $219.08M Ended 2023-03-31 | $1.01B Ended 2022-12-31 |
| 4 years earlier | $97.43M Ended 2021-12-31 | $235.19M Ended 2021-10-31 | $184.34M Ended 2022-03-31 | $1.04B Ended 2021-12-31 |